Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Protein quality control: the who s who, the where s and therapeutic escapes Roth J; Yam GH; Fan J; Hirano K; Gaplovska-Kysela K; Le Fourn V; Guhl B; Santimaria R; Torossi T; Ziak M; Zuber CHistochem Cell Biol 2008[Feb]; 129 (2): 163-77In cells the quality of newly synthesized proteins is monitored in regard to proper folding and correct assembly in the early secretory pathway, the cytosol and the nucleoplasm. Proteins recognized as non-native in the ER will be removed and degraded by a process termed ERAD. ERAD of aberrant proteins is accompanied by various changes of cellular organelles and results in protein folding diseases. This review focuses on how the immunocytochemical labeling and electron microscopic analyses have helped to disclose the in situ subcellular distribution pattern of some of the key machinery proteins of the cellular protein quality control, the organelle changes due to the presence of misfolded proteins, and the efficiency of synthetic chaperones to rescue disease-causing trafficking defects of aberrant proteins.|*Protein Folding[MESH]|Drug Design[MESH]|Endoplasmic Reticulum/*metabolism/ultrastructure[MESH]|Humans[MESH]|Membrane Proteins/physiology[MESH]|Metabolism, Inborn Errors/drug therapy/etiology[MESH]|Molecular Chaperones/*metabolism/therapeutic use[MESH]|Proteins/genetics/*metabolism[MESH] |
